ALT vs GILD: Which Stock is Better?
Side-by-side comparison of Altimmune Inc and Gilead Sciences Inc in 2026
ALT
Altimmune Inc
$3.60
GILD
Gilead Sciences Inc
$146.00
Key Metrics Comparison
| Metric | ALT | GILD | Winner |
|---|---|---|---|
| Market Cap | $475.88M | $184.43B | GILD |
| P/E Ratio | N/A | 21.94 | GILD |
| EPS (TTM) | $N/A | $6.77 | GILD |
| Revenue Growth | 4.2% | 0.0% | ALT |
| Gross Margin | -161929.3% | 78.8% | GILD |
Analyze ALT
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALT or GILD a better investment?
Comparing ALT and GILD: Altimmune Inc has a market cap of $475.88M while Gilead Sciences Inc has $184.43B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALT and GILD?
ALT (Altimmune Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALT or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALT or GILD?
ALT has higher revenue growth at 4.2% vs 0.0% for GILD.
Which company is more profitable: ALT or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -161929.3% for ALT.
Which is the larger company: ALT or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $184.43B compared to $475.88M for ALT.
Should I buy ALT or GILD in 2026?
Both ALT and GILD have investment merit. ALT trades at $3.60 while GILD trades at $146.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALT and GILD stock?
Key differences: Market Cap ($475.88M vs $184.43B), P/E Ratio (N/A vs 21.9x), Revenue Growth (4.2% vs 0.0%), Gross Margin (-161929.3% vs 78.8%).